314 related articles for article (PubMed ID: 27117828)
1. Advanced glycation endproducts and their receptor in different body compartments in COPD.
Hoonhorst SJ; Lo Tam Loi AT; Pouwels SD; Faiz A; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; van Oosterhout AJ; Lodewijk ME; Timens W; Postma DS; Ten Hacken NH
Respir Res; 2016 Apr; 17():46. PubMed ID: 27117828
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products in the skin are enhanced in COPD.
Hoonhorst SJ; Lo Tam Loi AT; Hartman JE; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; Postma DS; Ten Hacken NH
Metabolism; 2014 Sep; 63(9):1149-56. PubMed ID: 25034386
[TBL] [Abstract][Full Text] [Related]
3. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
[TBL] [Abstract][Full Text] [Related]
4. Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.
Gopal P; Reynaert NL; Scheijen JL; Engelen L; Schalkwijk CG; Franssen FM; Wouters EF; Rutten EP
Eur Respir J; 2014 Feb; 43(2):430-8. PubMed ID: 23645408
[TBL] [Abstract][Full Text] [Related]
5. Reduced soluble receptor for advanced glycation end-products in COPD.
Smith DJ; Yerkovich ST; Towers MA; Carroll ML; Thomas R; Upham JW
Eur Respir J; 2011 Mar; 37(3):516-22. PubMed ID: 20595148
[TBL] [Abstract][Full Text] [Related]
6. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
Iwamoto H; Gao J; Koskela J; Kinnula V; Kobayashi H; Laitinen T; Mazur W
Eur Respir J; 2014 Feb; 43(2):421-9. PubMed ID: 23794464
[TBL] [Abstract][Full Text] [Related]
7. Decreased plasma sRAGE levels in COPD: influence of oxygen therapy.
Gopal P; Rutten EP; Dentener MA; Wouters EF; Reynaert NL
Eur J Clin Invest; 2012 Aug; 42(8):807-14. PubMed ID: 22288943
[TBL] [Abstract][Full Text] [Related]
8. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
9. Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
Boschetto P; Campo I; Stendardo M; Casimirri E; Tinelli C; Gorrini M; Ceconi C; Fucili A; Potena A; Papi A; Ballerin L; Fabbri LM; Luisetti M
Eur J Clin Invest; 2013 Jun; 43(6):562-9. PubMed ID: 23590548
[TBL] [Abstract][Full Text] [Related]
10. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
[TBL] [Abstract][Full Text] [Related]
11. The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.
Lu T; Lahousse L; Wijnant S; Chen J; Brusselle GG; van Hoek M; Zillikens MC
Respir Res; 2024 Feb; 25(1):85. PubMed ID: 38336742
[TBL] [Abstract][Full Text] [Related]
12. The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
Miller S; Henry AP; Hodge E; Kheirallah AK; Billington CK; Rimington TL; Bhaker SK; Obeidat M; Melén E; Merid SK; Swan C; Gowland C; Nelson CP; Stewart CE; Bolton CE; Kilty I; Malarstig A; Parker SG; Moffatt MF; Wardlaw AJ; Hall IP; Sayers I
PLoS One; 2016; 11(10):e0164041. PubMed ID: 27755550
[TBL] [Abstract][Full Text] [Related]
13. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
[TBL] [Abstract][Full Text] [Related]
14. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.
Nienhuis HL; de Leeuw K; Bijzet J; Smit A; Schalkwijk CG; Graaff R; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2008 Oct; 47(10):1554-8. PubMed ID: 18701539
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.
Bakker SF; Tushuizen ME; Gözütok E; Çiftci A; Gelderman KA; Mulder CJ; Simsek S
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):230-5. PubMed ID: 25467215
[TBL] [Abstract][Full Text] [Related]
16. AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease.
Prasad K; Dhar I; Zhou Q; Elmoselhi H; Shoker M; Shoker A
Mol Cell Biochem; 2016 Dec; 423(1-2):105-114. PubMed ID: 27714575
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism.
Caspar-Bell G; Dhar I; Prasad K
Mol Cell Biochem; 2016 Mar; 414(1-2):171-8. PubMed ID: 26895319
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
